Literature DB >> 7655458

Mapping of a locus for progressive familial intrahepatic cholestasis (Byler disease) to 18q21-q22, the benign recurrent intrahepatic cholestasis region.

V E Carlton1, A S Knisely, N B Freimer.   

Abstract

A locus for progressive familial intrahepatic cholestasis (PFIC), also known as Byler disease, has been mapped to a 19 cM region of chromosome 18 by a search for shared segments, using patients from the Amish kindred in which the disorder was originally described. A similar liver disease, benign recurrent intrahepatic cholestasis (BRIC), recently has been mapped to the same region, suggesting that these two diseases are caused by mutations in the same gene. Although PFIC and BRIC are clinically distinct diseases, episodic attacks of jaundice and pruritus, with elevated concentrations of bile acid in serum, are seen in both disorders. In PFIC patients, these attacks result in progressive liver damage and death. The clinical and biochemical features of PFIC and BRIC are suggestive of a defect in primary bile acid secretion. The biology of bile secretion is of great interest because of its vital importance in digestion of dietary fats as well as in secretion of xenobiotics and metabolic waste products. Cloning of the gene (or genes) responsible for PFIC and BRIC will likely provide important insights into this pathway.

Entities:  

Mesh:

Year:  1995        PMID: 7655458     DOI: 10.1093/hmg/4.6.1049

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  17 in total

Review 1.  The molecular genetics of familial intrahepatic cholestasis.

Authors:  P L Jansen; M Müller
Journal:  Gut       Date:  2000-07       Impact factor: 23.059

2.  Molecular biology and the diagnosis and treatment of liver diseases.

Authors:  Howard J Worman; Lin Feng; Naoto Mamiya
Journal:  World J Gastroenterol       Date:  1998-06       Impact factor: 5.742

Review 3.  Hepatocellular transport proteins and their role in liver disease.

Authors:  C Stanca; D Jung; P J Meier; G A Kullak-Ublick
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

4.  Identification of a locus for progressive familial intrahepatic cholestasis PFIC2 on chromosome 2q24.

Authors:  S S Strautnieks; A F Kagalwalla; M S Tanner; A S Knisely; L Bull; N Freimer; S A Kocoshis; R M Gardiner; R J Thompson
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

5.  Locus heterogeneity in progressive familial intrahepatic cholestasis.

Authors:  S S Strautnieks; A F Kagalwalla; M S Tanner; R M Gardiner; R J Thompson
Journal:  J Med Genet       Date:  1996-10       Impact factor: 6.318

6.  Progressive familial intrahepatic cholestasis types 1, 2, and 3.

Authors:  P L Jansen; M M Müller
Journal:  Gut       Date:  1998-06       Impact factor: 23.059

7.  Modified laparoscopic external biliary diversion for benign recurrent intrahepatic cholestasis in obese adolescents.

Authors:  Martin L Metzelder; Claus Petersen; Michael Melter; Benno M Ure
Journal:  Pediatr Surg Int       Date:  2006-05-05       Impact factor: 1.827

8.  Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis.

Authors:  J M de Vree; E Jacquemin; E Sturm; D Cresteil; P J Bosma; J Aten; J F Deleuze; M Desrochers; M Burdelski; O Bernard; R P Oude Elferink; M Hadchouel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

Review 9.  Managing liver failure.

Authors:  D A Kelly
Journal:  Postgrad Med J       Date:  2002-11       Impact factor: 2.401

Review 10.  Cholestasis.

Authors:  R Oude Elferink
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.